Lab Services News for Bio/Pharmaceuticals

Welcome to Lab Services News for Bio/Pharmaceuticals. We explore the latest in bio/pharma testing requirements and product characterization, as well as providing details of our technical webinars and laboratory events.
Clear filters
Displaying 10 articles

SGS Opens New Laboratory in Qingdao, Increasing Its Chemical Testing Capabilities in China

A new SGS lab has opened in Qingdao, increasing the company’s chemical testing capabilities in China.

SGS Expands its Glasgow Facility, Increasing Biosafety Testing Capacity

We have expanded the capacity of our Glasgow testing facility, in a major boost to the development of cell therapies, gene therapies, viral vaccines and other biological medicines.

SGS Completes Investment and Expansion in New Testing Laboratories in Glasgow, UK

This project will see the construction of two new, fully equipped and fully staffed laboratories.

Vaccine Testing to Ensure Successful and Faster Vaccine Research and Development

Following its emergence earlier this year, the novel coronavirus (SARS-CoV-2) has spread rapidly and snowballed into a pandemic, taking a severe toll on almost every single nation in the world.

Managing Your Life Sciences Quality Management System Remotely

Learn how we've successfully managed our Life Sciences QMS during the pandemic.

SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate

We're providing biosafety, quality control and analytical testing services to AstraZeneca in support of the AZD1222 COVID-19 vaccine development.

SGS Appoints Franck Picard Business Manager of Life Sciences, France and Global Head of Bioanalysis

Franck Picard PhD joins SGS as Business Manager of Life Sciences in France and Global Head of Bioanalysis.

SGS Joins Forces with Leading Biotech ReiThera to Fast-Track its Single-Dose COVID-19 Vaccine

SGS joins forces with leading European biotech company ReiThera to fast-track a single-dose COVID-19 vaccine.

Nitrosamine Detection: Meet EMA and FDA Regulations

By April 2020, all marketing authorization holders of medicines containing chemically synthesized APIs must have conducted a risk assessment to evaluate the possibility of nitrosamines being present.

SGS Participates in The Value of Vaccines Campaign

The campaign features exclusive content from key thought leaders and industry voices about the need and ways to ensure vaccine safety and efficacy.